News + Filings Transactions
|
NEELS GUIDO J
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/16/2023 | Axogen, Inc. | AXGN | Purchase | Common Stock | 10k | $6.11 | $61.1k | | 08/16/2023 |
| 06/07/2023 | Bioventus Inc. | BVS | Grant | Restricted Stock Units | 30.4k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | Bioventus Inc. | BVS | Exercise | Restricted Stock Units | 16.6k | $0.00 | $0 | | 06/06/2023 |
| 06/01/2023 | Axogen, Inc. | AXGN | Exercise | Restricted Stock Units | 6.5k | $0.00 | $0 | | 06/01/2023 |
| 06/17/2022 | Bioventus Inc. | BVS | Grant | Restricted Stock Units | 16.6k | $0.00 | $0 | | 06/17/2022 |
| 06/01/2022 | Axogen, Inc. | AXGN | Exercise | Restricted Stock Units | 3k | $0.00 | $0 | | 06/01/2022 |
| 06/01/2022 | Axogen, Inc. | AXGN | Grant | Stock Option (right to purchase) | 11.8k | $9.29 | $109.7k | | 06/01/2022 |
| 06/01/2022 | Axogen, Inc. | AXGN | Grant | Restricted Stock Units | 6.5k | $0.00 | $0 | | 06/01/2022 |
| 04/01/2022 | Bioventus Inc. | BVS | Exercise | Restricted Stock Units | 2.7k | $0.00 | $0 | | 04/01/2022 |
| 02/11/2022 | Bioventus Inc. | BVS | Exercise | Restricted Stock Units | 9k | $0.00 | $0 | | 02/11/2022 |
| 06/01/2021 | Axogen, Inc. | AXGN | Grant | Stock Option (right to purchase) | 6k | $19.76 | $119.2k | | 06/01/2021 |
| 06/01/2021 | Axogen, Inc. | AXGN | Grant | Restricted Stock Units | 3k | $0.00 | $0 | | 06/01/2021 |
| 06/01/2021 | Axogen, Inc. | AXGN | Exercise | Restricted Stock Units | 6.2k | $0.00 | $0 | | 06/01/2021 |
| 05/19/2021 | Axogen, Inc. | AXGN | Exercise | Stock Option (right to buy) | 25k | $3.80 | $95k | | 05/19/2021 |
| 05/19/2021 | Axogen, Inc. | AXGN | Exercise | Stock Option (right to purchase) | 15k | $5.09 | $76.4k | | 05/19/2021 |
| 05/19/2021 | Axogen, Inc. | AXGN | Exercise | Stock Option (right to purchase) | 15k | $5.09 | $76.4k | | 05/19/2021 |
| 05/19/2021 | Axogen, Inc. | AXGN | Exercise | Stock Option (right to buy) | 25k | $3.80 | $95k | | 05/19/2021 |
| 04/01/2021 | Bioventus Inc. | BVS | Grant | Restricted Stock Units | 2.7k | $0.00 | $0 | | 04/01/2021 |
| 02/11/2021 | Bioventus Inc. | BVS | Grant | Restricted Stock Units | 9k | $0.00 | $0 | | 02/11/2021 |
| 09/03/2020 | Axogen, Inc. | AXGN | Grant | Common Stock | 2.6k | $11.75 | $30.4k | | 09/03/2020 |
| 06/01/2020 | Axogen, Inc. | AXGN | Grant | Stock Option (right to purchase) | 16.8k | $9.72 | $163.4k | | 06/01/2020 |
| 06/01/2020 | Axogen, Inc. | AXGN | Grant | Restricted Stock Units | 4.1k | $0.00 | $0 | | 06/01/2020 |
| 06/01/2020 | Axogen, Inc. | AXGN | Grant | Restricted Stock Units | 6.2k | $0.00 | $0 | | 06/01/2020 |
| 06/01/2020 | Axogen, Inc. | AXGN | Grant | Stock Option (right to purchase) | 12.6k | $9.72 | $122.5k | | 06/01/2020 |
| 09/03/2019 | Axogen, Inc. | AXGN | Grant | Restricted Stock Units | 2.6k | $0.00 | $0 | | 09/03/2019 |
| 09/03/2019 | Axogen, Inc. | AXGN | Grant | Stock Option (right to purchase) | 10.7k | $15.44 | $165.4k | | 09/03/2019 |
| 04/03/2019 | ENDOLOGIX INC /DE/ | ELGX | Purchase | Common Stock | 22.7k | $6.61 | $150k | | 04/03/2019 |
| 12/30/2018 | ENDOLOGIX INC /DE/ | ELGX | Grant | Common Stock | 120.9k | $0.00 | $0 | | 12/30/2018 |
| 06/01/2018 | Axogen, Inc. | AXGN | Grant | Stock Option (right to purchase) | 4.8k | $49.65 | $237.3k | | 06/01/2018 |
| 02/28/2018 | ENTELLUS MEDICAL INC | ENTL | Disposition | Common Stock, $0.001 par value | 17.5k | $24.00 | $420k | | 02/28/2018 |
| 02/28/2018 | ENTELLUS MEDICAL INC | ENTL | Disposition | Stock Option (right to buy) | 15k | $11.36 | $170.4k | | 02/28/2018 |
| 02/28/2018 | ENTELLUS MEDICAL INC | ENTL | Disposition | Stock Option (right to buy) | 10k | $18.26 | $182.6k | | 02/28/2018 |
| 02/28/2018 | ENTELLUS MEDICAL INC | ENTL | Disposition | Stock Option (right to buy) | 5k | $13.38 | $66.9k | | 02/28/2018 |
| 11/20/2017 | Axogen, Inc. | AXGN | Sale | Common Stock | 1.2M | $19.74 | $22.7M | By Essex Woodlands Fund IX, L.P. | 11/20/2017 |
| 06/13/2017 | ENTELLUS MEDICAL INC | ENTL | Grant | Stock Option (right to buy) | 5k | $13.38 | $66.9k | | 06/13/2017 |
|
|